CD163 and neoplasm: Our next objective was to investigate macrophage populations in the breast TMA by first analyzing the expression of CD14 (monocytes), CD68 (all macrophages), and CD163 (M2 macrophages), and further stratifying the expression of these markers within PDLIM2-positive and -negative tumours.